Chr. Hansen enters into partnership with Rheolution Inc. on cheesemaking aids

a4dff4b5-d273-4662-9dda-e188bbd55b68articleimage.jpg

30 Nov 2017 --- Chr. Hansen has entered into a partnership with Rheolution Inc. on the global distribution of Rheolution's CoaguSens and ElastoSens products. Aimed at cheesemakers, Chr. Hansen explains that the products offer real-time analytics of the milk coagulation process: In real time and near the vats, they measure the flocculation point (where solid particles are separated from the liquid), the milk gel firmness and the speed of coagulation.

The milk gel-cutting step is often the least controlled step in the cheesemaking process, but with the insights that this technology can derive, Chr. Hansen asserts that cheesemakers will know precisely the optimal time to cut the cheese curd at a controlled firmness. This will enable them to retain the greatest amount of protein and fat from the milk in their cheese, thus increasing the overall value generated from the milk processed.
 
“Perfect synergy”
“Rheolution has chosen Chr. Hansen as its strategic sales partner because of the perfect synergy between the core expertise of the two companies,” says Anis Hadj Henni, CEO, Rheolution Inc. “Rheolution delivers high-quality process control instruments and technical support to monitor the coagulation of milk. Chr. Hansen, as a recognized leader in the culture and enzyme industry with a strong focus on innovation, brings valuable expertise on cheese making technology and a global commercialization network.”
 
“Together, we look forward to improving the quality and yield of cheese and fresh fermented products,” Henni adds. “We also hope to benefit the environment by minimizing food waste in the dairy industry.”
 
Expanding product portfolio
Chr. Hansen has announced that the new partnership doesn’t only expand its product portfolio, which already includes top of the line coagulants, cheese cultures and tests, to include real-time data analysis tools. It also strengthens the company’s role as the go-to solutions provider for cheese producers worldwide.
 
“Our partnership with Rheolution brings us one step closer to the practical use of digitalization to optimize the coagulation in the cheese vat. I am convinced that partnering with Rheolution brings innovative expertise and concrete data processing excellence to the table, and jointly we will make CoaguSens the reference technology for the dairy industry and further develop the analytical applications of the products,” says Soeren Herskind, Vice President, Cheese, Chr. Hansen.
 
CoaguSens and ElastoSens are already up and running for cheese producers throughout the US, Canada, and Europe. Chr. Hansen expects to further develop these markets and continue to grow reach globally.
 
“The products are convenient and require very little time to get up and running. We like to refer to them as data-driven aids to the art of cheesemaking – and they come with Chr. Hansen's first-rate service and renowned application assistance on the spot,” concludes Herskind.
 
“Innovative response”
Chr. Hansen has described CoaguSens as follows:
 
• CoaguSens is an innovative response to the dairy industry’s need for better control over milk coagulation.
• It was designed with cheesemakers for cheesemakers.
• CoaguSens can be used to automate operations and collect at line production data. The collection and use of this data could reshape the dairy industry by increasing plant efficiency and product quality.
 
In other company news, Soeren Westh Lonning, CFO at Chr. Hansen, recently discussed the company’s organic growth plans in a podcast interview with NutritionInsight’s sister website FoodIngredientsFirst.

Chr. Hansen

Collapse

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Related Articles

Business News

Dow to expand propionic acid facility in Texas

15 Dec 2017 --- Dow Industrial Solutions, a business unit of The Dow Chemical Company, announced plans to expand its propionic acid facility in Texas City, Texas to meet rising global demand. The propionic acid market continues to grow as a result of megatrends for longer lasting foods and animal feed and grain alternatives. Dow’s plant expansion supports this growth and follows debottlenecking projects completed at the Texas City facility in 2015 and 2017.

Regulatory News

EU Parliament rejects calls for phosphate ban

14 Dec 2017 --- A proposal to ban the additive phosphate, a key component in kebabs and gyros, has been narrowly defeated in European Parliament following a vote yesterday (December 13).The legislature fell three votes short of reaching an absolute majority of at least 376 votes for a phosphate ban, which would have seriously impacted the kebab industry, forcing it to find alternatives rather than stop producing the highly popular fast food.

Food Ingredients News

Innovation success for alternative proteins at FiE

13 Dec 2017 --- Alternative proteins had a strong presence at FiE in Frankfurt last month. Exhibitors showed a sustained focus on alternative protein concepts, with a number of innovations and concepts creating a real buzz at this year’s show. FoodIngredientsFirst looks at a few of the offerings being exhibited at this year’s event.

Food Research

New report reveals salmonella cases no longer falling in the EU

12 Dec 2017 --- The declining trend of salmonellosis cases in the EU has leveled off according to the annual report on zoonotic diseases published this week. Cases of Salmonella Enteritidis acquired in the EU have increased in humans by 3 percent since 2014 says the report, which is compiled by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA). In laying hens, the prevalence increased from 0.7 percent to 1.21 percent over the same period. 

Business News

GEA finalizes Chr Hansen's vast fermentation plant for cultures

12 Dec 2017 --- A successful collaboration between GEA and Chr. Hansen was completed with the inauguration of the world’s largest fermentation plant for bacterial cultures at the customer’s site in Copenhagen, Denmark on November 23, 2017. 

More Articles